EA201891301A1 - ANTIBODIES AGAINST DR5 AND METHODS OF THEIR USE - Google Patents
ANTIBODIES AGAINST DR5 AND METHODS OF THEIR USEInfo
- Publication number
- EA201891301A1 EA201891301A1 EA201891301A EA201891301A EA201891301A1 EA 201891301 A1 EA201891301 A1 EA 201891301A1 EA 201891301 A EA201891301 A EA 201891301A EA 201891301 A EA201891301 A EA 201891301A EA 201891301 A1 EA201891301 A1 EA 201891301A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- relates
- molecules
- methods
- antibodies against
- antigen
- Prior art date
Links
Abstract
Изобретение касается молекул моноспецифичных или биспецифических антител, специфически связывающих антиген DR5 человека. В частности, изобретение касается DR5-специфичных молекул антител изотипа IgG1, содержащих мутацию в Fc-области, которая усиливает кластеризацию молекул IgG после связывания с поверхностным антигеном, что ведет к запуску сигнализации DR5, апоптозу и клеточной смерти. Изобретение также касается комбинации молекул антител, связывающих различные эпитопы на DR5. Изобретение также касается фармацевтических композиций, содержащих такие молекулы, и лечения рака с помощью этих композиций.The invention relates to molecules of monospecific or bispecific antibodies that specifically bind the human DR5 antigen. In particular, the invention relates to DR5-specific antibody molecules of the IgG1 isotype containing a mutation in the Fc region that enhances clustering of IgG molecules after binding to a surface antigen, leading to triggering DR5 signaling, apoptosis and cell death. The invention also relates to a combination of antibody molecules that bind different epitopes on DR5. The invention also relates to pharmaceutical compositions containing such molecules and the treatment of cancer with these compositions.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA201600702 | 2016-11-10 | ||
PCT/EP2016/079518 WO2017093448A1 (en) | 2015-12-01 | 2016-12-01 | Anti-dr5 antibodies and methods of use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201891301A1 true EA201891301A1 (en) | 2021-08-18 |
Family
ID=77515143
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201891301A EA201891301A1 (en) | 2016-11-10 | 2016-12-01 | ANTIBODIES AGAINST DR5 AND METHODS OF THEIR USE |
Country Status (1)
Country | Link |
---|---|
EA (1) | EA201891301A1 (en) |
-
2016
- 2016-12-01 EA EA201891301A patent/EA201891301A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201803079B (en) | Anti-dr5 antibodies and methods of use thereof | |
CY1124771T1 (en) | ANTI-SORTILINE ANTIBODIES AND METHODS OF USING THEM | |
CL2019001926A1 (en) | Anti-tigit antibodies and antigen-binding fragments; pharmaceutical composition comprising them; polynenucleotide encoding said antibody; vector comprising them, host cell; method of producing said antibody or antigen-binding fragment thereof; and use in the treatment of cancer. (Divisional Application 310-2017). | |
EA201992402A1 (en) | ANTIBODIES AGAINST ILT4 AND ANTIGEN-BINDING FRAGMENTS | |
PH12019500545A1 (en) | Cd3 binding antibodies | |
PH12018501554A1 (en) | Ror1 antibody compositions and related methods | |
MX2018016404A (en) | Cd3 binding antibodies. | |
EA202092417A1 (en) | CHIMERIC RECEPTORS TO DLL3 AND METHODS OF THEIR APPLICATION | |
WO2017075432A3 (en) | Anti-siglec-9 antibodies and methods of use thereof | |
AR096617A1 (en) | ANTI-TWEAKR ANTIBODIES AND THEIR USES | |
MX2020012567A (en) | Anti-ox40 antibodies and methods of use. | |
AR100680A1 (en) | ANTI-DR5 ANTIBODIES AND MOLECULES THAT INCLUDE DR5 JOINT DOMAINS OF THE SAME | |
MX2019011520A (en) | Bispecific anti-cd37 antibodies, monoclonal anti-cd37 antibodies and methods of use thereof. | |
EA202091747A1 (en) | ANTIBODY B7-H4 COMPOSITIONS | |
MX2018012473A (en) | Humanized anti clever-1 antibodies and their use. | |
AR109683A1 (en) | ANTIBODIES AGAINST FACTOR XI AND ITS USES | |
EA201892313A1 (en) | HUMANIZED ANTIBODIES AGAINST CLEVER-1 AND THEIR APPLICATION | |
EA202190183A1 (en) | ANTIBODIES TO SIGLEC-5 AND METHODS OF THEIR APPLICATION | |
MX2020008730A (en) | B7-h4 antibody dosing regimens. | |
ZA202008095B (en) | Humanized antibodies against psma | |
MX2019014407A (en) | Therapeutic antibodies based on mutated igg hexamers. | |
EA202090791A1 (en) | AGONISM ANTIBODIES AGAINST CD40 | |
MX2020006155A (en) | Bispecific cd 16-binding molecules and their use in the treatment of disease. | |
EA202092595A1 (en) | ANTIBODIES TO SIGLEC-7 AND METHODS OF THEIR APPLICATION | |
MX2021003756A (en) | Pharmaceutical compositions comprising bispecific anti-cd37 antibodies. |